Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02123121 · ClinicalTrials.gov registry record · Phase 2
Resveratrol to Enhance Vitality and Vigor in Elders
A Phase 2 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT02123121 is a Phase 2 study that has completed, run by University of Florida. The registered enrollment target is 60 participants.
The verdict
NCT02123121, a Phase 2 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
Resveratrol, a compound found in red wine and dark-skinned grapes, will improve the function of mitochondria (energy producing components) within the leg muscles of moderate functioning older adults. The investigators will look at the role Resveratrol plays in improving physical function by studying the connection of changes in mitochondrial function and changes in physical function.
Interventions
- DRUG Resveratrol 1000 mg/day
- DRUG Resveratrol 1500 mg/day
- OTHER Vegetable cellulose
- OTHER All groups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-05-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02123121
The ClinicalTrials.gov registry entry for NCT02123121 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Resveratrol 1000 mg/day is the first listed.
NCT02123121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02123121 about?
NCT02123121 is a clinical study titled "Resveratrol to Enhance Vitality and Vigor in Elders". Resveratrol, a compound found in red wine and dark-skinned grapes, will improve the function of mitochondria (energy producing components) within the leg muscles of moderate functioning older adults. The investigators will look at the role Resveratrol plays in improving physical function by studyin...
What is the current status of trial NCT02123121?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2015-09. Estimated completion is 2019-05-02.
What interventions are being tested in trial NCT02123121?
The interventions under investigation include: Resveratrol 1000 mg/day (DRUG), Resveratrol 1500 mg/day (DRUG), Vegetable cellulose (OTHER), All groups (OTHER).
Who is sponsoring clinical trial NCT02123121?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.